Prakt. Lékáren. 2017; 13(1e) [Psychiatr. praxi. 2016;17(3):98-102]

A new nomenclature for psychotropic agents (Neuroscience-based Nomenclature)

Libor Ustohal
Psychiatrická klinika Lékařské fakulty Masarykovy univerzity a Fakultní nemocnice Brno
CEITEC MU, Brno

The article presents a proposal for a new psychopharmacological nomenclature introduced by leading persons of international neuropsychopharmacologicalsocieties. The aim of this nomenclature, marked as Neuroscience-based Nomenclature (NbN), is to classify psychotropicagents by their pharmacological profile. It was developed to provide more rational choice of medication by its mechanism of action. The lastversion of this nomenclature is focused on pharmacological domains and modes/mechanisms of action. NbN also includes four additionaldimensions: approved indication, efficacy and side effects, practical notes and neurobiology.

Keywords: psychotropic drugs, nomenclature, neuroscience

Received: May 29, 2019; Accepted: May 30, 2019; Prepublished online: May 30, 2019; Published: April 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ustohal L. A new nomenclature for psychotropic agents (Neuroscience-based Nomenclature). Praktické lékárenství. 2017;13(E-verze 1/17):.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Zohar J, Nutt DJ, Kupfer DJ, Moller HJ, Yamawaki S, Spedding M, Stahl SM. A proposal for an updated neuropsychopharmacological nomenclature. Eur Neuropsychopharmacol 2014; 24: 1005-1014. Go to original source... Go to PubMed...
    2. The original proposed list of 109 compounds [on-line]. [citováno 18. 4. 2016]. Dostupný na http://www.ecnp.eu/projects-initiatives/nomenclature.aspx.
    3. Zohar J, Stahl S, Möller HJ, Blier P, Kupfer D, Yamawaki S, Uchida H, Spedding M, Goodwin G, Nutt D. Neuroscience based nomenclature. Cambridge: Cambridge University Press 2014: 254.
    4. Zohar J, Stahl S, Moller HJ, Blier P, Kupfer D, Yamawaki S, Uchida H, Spedding M, Goodwin G, Nutt D. A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature. Eur Neuropsychopharmacol 2015; 25: 2318-2325. Go to original source... Go to PubMed...

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.